Follow-up products from blood and genetic data: a guide for labs and data owners

Reviewed by Dr. Daniel Wallerstorfer, molecular biologist and founder of Novogenia · Updated: 13 October 2026 · Reading time: 7 min

In short

Labs, DNA testing companies and health platforms have something no manufacturer can create on its own: data on individual people, and their trust. From genetic data, blood values and a questionnaire, a personal supplement formula can be calculated for each person; genetic data can also drive personalized skincare. At Novogenia, a genetic lab, a supplement factory and a cosmetics factory sit under one roof in Eugendorf near Salzburg, Austria. In three chapters, this guide covers the principle and the business models, the path from measurement to formula, and implementation: data integration, data protection, your own brand and a pilot.

Your data is the recipe – we are the kitchen

What actually gets people to change? The European Food4Me study tested this in seven countries; 1,269 adults completed it. Those who received personalized nutrition advice – depending on the group, based on their own diet, on their diet plus body measurements and blood values, or on all of that plus their genes – ate less red meat, salt and saturated fat after six months and took in more folate than the control group given general advice (Celis-Morales et al., International Journal of Epidemiology, 2017).

The logical conclusion: data unfold their power when they turn into something personal. A lab result is like a recipe. It describes how a person is built and where they stand right now. But a recipe alone never fed anyone – it takes a kitchen that cooks a dish of its own for every single person.

I am a molecular biologist and the founder of Novogenia. In our building in Eugendorf near Salzburg, Austria, a genetic lab, a supplement factory and a cosmetics factory sit under one roof. We are the kitchen. With this guide, I want to show you how your blood and genetic data can become follow-up products that your customers hold in their hands every day.

Who this guide is for

For everyone who collects or holds data on individual people – and wants to offer them more than a result:

Diagnostic and blood labs: you measure vitamins, minerals and other lab markers and are looking for a product that builds on the result.
DNA testing companies and genetic labs: you analyze, but you do not manufacture.
Health and longevity platforms: you hold genotype or biomarker data from your users.
Health-check providers and clinics: you accompany people across several checkups.
Corporate health programs: you want to give employees a personal offer (more in Corporate health programs).

All of them share a strength that no manufacturer can buy: you have the data, and your customers trust you.

What your data can become

Three kinds of follow-up products can be derived from lab and genetic data:

Personalized supplements: a formula of its own for each person, calculated from around 50 genes, blood values, a questionnaire, and sex, age and body weight. Each nutrient sits in its own Microtransporters; one delivery lasts 90 days.
Personalized skincare: day serum, night serum and body lotion. The genetic result changes which ingredients go in and at what dosage.
Genetic analyses with a report: if you only measure blood values so far, you can add lifestyle analyses, for example on nutrition – with reports in up to 18 languages, under your brand on request.

How you offer them is up to you: through a partner shop with a commission on every order, as white label under your brand, or through your own product development. If you already have data, you bring it in as a data partner; we interpret it and make the product. The customer relationship stays with you.

How data sources, calculation and production fit together from the manufacturing side is already explained in the chapter Personalized supplement manufacturing in our contract manufacturing guide. This guide takes your side – the data owner’s: your data, your role, your integration and your business model.

Specially protected data: the EU and Switzerland

Genetic data and blood values are not ordinary data. In the EU, genetic data and data concerning health are special categories under Article 9 of the General Data Protection Regulation (GDPR). Processing them is prohibited in principle unless an exception applies – for example, the explicit consent of the person concerned (Art. 9(2)(a) GDPR). In Germany and Austria, the GDPR applies directly.

Switzerland has its own Federal Act on Data Protection (FADP, in German DSG). It classifies health data and genetic data as sensitive personal data (Art. 5 let. c FADP). The FADP has no general prohibition with exceptions like the GDPR. Where consent is required, however, it must be given explicitly for such data (Art. 6 para. 7 FADP). And anyone who discloses sensitive personal data to third parties needs a ground for justification, such as consent (Art. 30 para. 2 let. c and Art. 31 FADP).

For you, this means: before the first data record moves, clarify who has which role and how consent is obtained, and put it in the contract. Roles, consent and the Swiss specifics are covered in detail in Data protection and roles between lab and manufacturer.

Chapter 1 · The principle

Why data is the start of a product, which business model suits you, and how a one-time test turns into a lasting customer relationship.

Turning lab and genetic data into productsThe chain from data through rule set and formula to delivery. Business models for labs and data ownersPartner shop, white label, own development and data partnership compared. Recurring revenue from follow-up productsWhy a product on a 90-day rhythm turns a test into a relationship.

Chapter 2 · From measurement to formula

How blood values and genes set the dose of each nutrient – and which limits always apply.

From blood values to a formulaHow blood values steer the formula and why they take precedence over genes. From genetic data to a formulaAround 50 genes, a questionnaire and the three-study rule: how a genetic profile becomes a dose. Dosing and safety: limits and rulesDosing window, EFSA upper limits and national rules in Germany, Austria and Switzerland.

Chapter 3 · Implementation

What to clarify before you start: data transfer, data protection, your brand and the pilot.

Data integration: raw data, interfaces, formatsWhich data you hand over and what to settle before the first record. Data protection and roles between lab and manufacturerGDPR, the Swiss FADP and consent: who takes on which role. Follow-up products under your brandLabel, packaging, daily servings and skincare with your name on them. Launch and pilot: introducing follow-up productsFrom idea to pilot to scale, step by step.

How we do it at Novogenia

What you can expect from Novogenia:

Everything under one roof: a genetic lab, a supplement factory and a cosmetics factory in one building in Eugendorf near Salzburg, Austria.
Your data or a fresh saliva sample: We interpret usable genotype or SNP data and blood values. If genetic data are missing, we supply saliva kits, branded with your design on request; the analysis in our own lab takes 4 days.
A clear rule set: around 50 genes with three possible genotypes each; every gene is backed by at least three independent studies. Blood values take precedence for the nutrient concerned.
Fixed limits: every dose between one third and three times the reference intake, with documented exceptions, and always at or below the EFSA upper limit.
Production from a single unit: one formula per person in Microtransporters; one delivery lasts 90 days.
Three routes: a partner shop with a commission on every order and no setup fees, white label under your brand, or your own product development.
Quality: CLIA-certified and working according to ISO 15189; ISO 9001:2015, ISO 22000:2018 and ISO 22716, certified by Quality Austria.
Experience: since 2009, more than 30 million analyses performed, partners in 69 countries – Novogenia sells exclusively through partners.

Frequently asked questions

What data do I need for a follow-up product?

Genetic data, blood values or a diet and lifestyle questionnaire – alone or combined – plus sex, age and body weight. We can interpret usable raw genotype or SNP data; whether they cover the genes needed is checked in the project. If genetic data are missing, a fresh saliva sample is an option.

Does my lab have to manufacture anything itself?

No. At Novogenia, interpretation, formulation, manufacturing, packaging and shipping come from a single source. You coordinate one partner instead of several suppliers.

Do I get software that calculates the formula?

No. At Novogenia, interpretation is a service, not software that you run on your own. We apply the rule set and make the product. If you have your own calculation logic, you can also specify the composition yourself.

Under whose name are the follow-up products sold?

You decide: through a partner shop, as white label under your own brand, or as your own product. The customer relationship stays with you. Legal information duties, for example about who receives the data, apply in every model.

Are personalized supplements a treatment?

No. They are food supplements that optimize intake within the healthy range. A genuine deficiency, abnormal blood values or a medical condition belong in a physician’s hands. That is why marketing claims make no promise of cure.

Follow-up products for your data?

Tell us which data you hold and who your customers are – we will show you which follow-up product fits.

Request a project →Offer for labs

Note: This guide is general information for businesses and professionals and does not replace medical or legal advice. The genetic traits determined in a genetic analysis are well documented (each gene included is backed by at least three independent studies); recommendations derived from them are logical conclusions, not scientifically proven. Regulations can change; errors and changes excepted.